74.90
-2.49
(-3.22%)
At close: March 12 at 1:57:50 PM GMT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 8 | 6 | 24 | 24 |
| Avg. Estimate | 13.73B | 13.97B | 57.26B | 60.76B |
| Low Estimate | 13.34B | 13.67B | 53.93B | 55.89B |
| High Estimate | 14.02B | 14.79B | 59.66B | 66.5B |
| Year Ago Sales | 12.68B | 12.94B | 54.07B | 57.26B |
| Sales Growth (year/est) | 8.27% | 8.00% | 5.90% | 6.11% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 0A4J.L | -- | -- | -- | -- |
| S&P 500 | 6.68% | 6.74% | 9.91% | 14.34% |
Upgrades & Downgrades
| Upgrade | UBS: Neutral to Buy | 2/13/2025 |
| Upgrade | UBS: Sell to Neutral | 11/20/2024 |
| Upgrade | Erste Group: Hold to Buy | 9/11/2024 |
| Maintains | TD Cowen: Buy to Buy | 8/12/2024 |
| Maintains | Argus Research: Buy to Buy | 5/30/2024 |
| Initiated | Goldman Sachs: Buy | 5/30/2024 |